Innovita Biological Technology Co., Ltd. (SHA:688253)
China
· Delayed Price · Currency is CNY 34.73
-0.07 (-0.20%)
At close: Mar 9, 2026
SHA:688253 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | - | 307.73 | 166.46 | 388.67 | 479.74 | Upgrade
|
| Trading Asset Securities | - | 1,584 | 1,531 | 1,115 | 87.25 | Upgrade
|
| Cash & Short-Term Investments | 1,849 | 1,892 | 1,697 | 1,503 | 566.99 | Upgrade
|
| Cash Growth | -2.28% | 11.49% | 12.89% | 165.14% | -4.92% | Upgrade
|
| Accounts Receivable | - | 37.83 | 105.17 | 124.31 | 4.13 | Upgrade
|
| Other Receivables | - | 1.95 | 1.68 | 10.63 | 0.27 | Upgrade
|
| Receivables | - | 39.78 | 106.86 | 134.95 | 4.4 | Upgrade
|
| Inventory | - | 43.47 | 61.51 | 74.8 | 43.63 | Upgrade
|
| Other Current Assets | - | 22.21 | 7.2 | 24.46 | 32.81 | Upgrade
|
| Total Current Assets | - | 1,998 | 1,873 | 1,738 | 647.83 | Upgrade
|
| Property, Plant & Equipment | - | 120.21 | 118.39 | 130.29 | 116.93 | Upgrade
|
| Long-Term Investments | - | 35.65 | 34.26 | 14.94 | 5 | Upgrade
|
| Other Intangible Assets | - | 6.79 | 7.02 | 7.25 | 7.49 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 22.65 | 13.41 | 2.26 | 1.22 | Upgrade
|
| Long-Term Deferred Charges | - | 11.19 | 8.65 | 12.02 | 7.31 | Upgrade
|
| Other Long-Term Assets | - | 18.42 | 11.31 | 38.3 | 12.1 | Upgrade
|
| Total Assets | - | 2,212 | 2,066 | 1,943 | 797.87 | Upgrade
|
| Accounts Payable | - | 90.93 | 63.57 | 71.56 | 21.16 | Upgrade
|
| Accrued Expenses | - | 41.94 | 25.37 | 27.44 | 20.31 | Upgrade
|
| Short-Term Debt | - | - | - | 17.62 | - | Upgrade
|
| Current Portion of Leases | - | 3.2 | 1.96 | 3.01 | 0.88 | Upgrade
|
| Current Income Taxes Payable | - | 0.95 | 16.34 | 4.31 | 2.64 | Upgrade
|
| Current Unearned Revenue | - | 57.25 | 100.66 | 105.1 | 5.9 | Upgrade
|
| Other Current Liabilities | - | 15.94 | 7.34 | 14.06 | 1.27 | Upgrade
|
| Total Current Liabilities | - | 210.21 | 215.23 | 243.11 | 52.15 | Upgrade
|
| Long-Term Leases | - | 2.57 | 1.04 | 2.49 | 0.52 | Upgrade
|
| Long-Term Unearned Revenue | - | 3.14 | 4.8 | 6.33 | 6.99 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 3.15 | 2.58 | 1.31 | 0.05 | Upgrade
|
| Total Liabilities | - | 219.07 | 223.65 | 253.24 | 59.7 | Upgrade
|
| Common Stock | - | 136.46 | 136.06 | 136.06 | 102.04 | Upgrade
|
| Additional Paid-In Capital | - | 1,036 | 1,024 | 1,022 | 255.67 | Upgrade
|
| Retained Earnings | - | 874.94 | 682.51 | 531.15 | 380.46 | Upgrade
|
| Treasury Stock | - | -50.01 | - | - | - | Upgrade
|
| Comprehensive Income & Other | - | -3.65 | -1.02 | - | - | Upgrade
|
| Total Common Equity | 2,032 | 1,993 | 1,842 | 1,689 | 738.17 | Upgrade
|
| Shareholders' Equity | 2,032 | 1,993 | 1,842 | 1,689 | 738.17 | Upgrade
|
| Total Liabilities & Equity | - | 2,212 | 2,066 | 1,943 | 797.87 | Upgrade
|
| Total Debt | 5.09 | 5.77 | 3 | 23.12 | 1.4 | Upgrade
|
| Net Cash (Debt) | 1,844 | 1,886 | 1,694 | 1,480 | 565.59 | Upgrade
|
| Net Cash Growth | -2.25% | 11.35% | 14.45% | 161.71% | -3.73% | Upgrade
|
| Net Cash Per Share | 13.51 | 13.83 | 12.47 | 12.18 | 5.55 | Upgrade
|
| Filing Date Shares Outstanding | 136 | 134.87 | 136.06 | 136.06 | 102.04 | Upgrade
|
| Total Common Shares Outstanding | 134.87 | 134.87 | 136.06 | 136.06 | 102.04 | Upgrade
|
| Working Capital | - | 1,787 | 1,657 | 1,494 | 595.68 | Upgrade
|
| Book Value Per Share | 15.07 | 14.78 | 13.54 | 12.42 | 7.23 | Upgrade
|
| Tangible Book Value | 2,022 | 1,987 | 1,835 | 1,682 | 730.68 | Upgrade
|
| Tangible Book Value Per Share | 14.99 | 14.73 | 13.49 | 12.36 | 7.16 | Upgrade
|
| Buildings | - | 97.96 | 97.96 | 94.67 | 85.39 | Upgrade
|
| Machinery | - | 98.21 | 86.21 | 77.17 | 61.21 | Upgrade
|
| Construction In Progress | - | 2.37 | - | - | 0.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.